Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 3,531 | 3,833 | 4,566 | 5,765 | 7,103 |
| Cost of Goods | 1,632 | 1,712 | 1,950 | 3,838 | 5,118 |
| Gross Profit | 1,899 | 2,121 | 2,616 | 1,927 | 1,985 |
| Operating Expenses | 15,429 | 12,838 | 13,060 | 9,614 | 7,958 |
| Operating Income | -12,898 | -10,005 | -9,494 | -6,849 | -5,855 |
| Interest Expense | 45 | 22 | 20 | 6 | 3 |
| Other Income | 315 | 48 | 1,480 | -362 | -62 |
| Pre-tax Income | -12,628 | -9,979 | -8,034 | -7,217 | -5,920 |
| Income Tax | 5 | 17 | N/A | N/A | N/A |
| Net Income Continuous | -12,633 | -9,996 | -8,034 | -7,217 | -5,920 |
| Net Income | $-12,633 | $-9,996 | $-8,034 | $-7,217 | $-5,920 |
| EPS Basic Total Ops | -1.60 | -1.40 | -1.20 | -1.00 | -1.00 |
| EPS Basic Continuous Ops | -1.66 | -1.35 | -1.10 | -1.08 | -0.93 |
| EPS Diluted Total Ops | -1.60 | -1.40 | -1.20 | -1.00 | -1.00 |
| EPS Diluted Continuous Ops | -1.66 | -1.35 | -1.10 | -1.08 | -0.93 |
| EBITDA(a) | $-12,248 | $-9,462 | $-9,062 | $-6,443 | $-5,449 |